Cargando…
Clinico-pathological classification of rheumatic mitral valve damage and surgical strategy
BACKGROUND: There is a lack of established pathological indications for rheumatic valve repair. Therefore, we summarized the pathological classifications of rheumatic heart diseases and their correlations with the surgical strategies. METHODS: This observational study enrolled patients with rheumati...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182522/ https://www.ncbi.nlm.nih.gov/pubmed/34164184 http://dx.doi.org/10.21037/jtd-20-3456 |
_version_ | 1783704223963152384 |
---|---|
author | Luo, Tiange Meng, Xu |
author_facet | Luo, Tiange Meng, Xu |
author_sort | Luo, Tiange |
collection | PubMed |
description | BACKGROUND: There is a lack of established pathological indications for rheumatic valve repair. Therefore, we summarized the pathological classifications of rheumatic heart diseases and their correlations with the surgical strategies. METHODS: This observational study enrolled patients with rheumatic heart diseases who underwent mitral valve repair (MVP) or replacement at our centre between January 2017 and January 2019. Mitral leaflet, mitral commissural, and sub-valvular apparatus were classified into three grades from mild to severe, according to their degree of pathological damage. Based on certain principles and the grade of mitral leaflet, mitral commissural, and sub-valvular apparatus damage, three pathological types were identified (types I to III), based on which all patients were classified. The features of each pathological type were summarised. Differences between the three pathological types were analysed using chi-square test of tendency. These data were used to propose a clinico-pathological classification of rheumatic mitral valve damage in Chinese patients. RESULTS: Of 398 patients, 284 (70%) underwent MVP for rheumatic mitral valve diseases. There were 58 type I (15%) patients in the study, all of whom underwent repair (repair rate, 100%). Preoperative moderate-to-severe regurgitation with mild pathological lesions was observed in 64% of these patients. In 260 type II (65%) patients, the repair rate was 76% (197/260); preoperative moderate-to-severe stenosis was observed in 88% of these patients. In 80 type III (20%) patients, the repair rate was 36% (29/80); the preoperative rates of extremely severe stenosis and moderate-to-severe regurgitation in these patients were 50% and 40%, respectively. Several preoperative parameters show the change in trend with the increase in the pathological classification severity. CONCLUSIONS: Our clinico-pathological classification of rheumatic mitral valve damage is applicable to MVP. Considering that the classification principles are based on the possibility of mitral repair, it provides a phased and achievable target ratio for MVP and a principle of screening patients who should undergo rheumatic MVP. |
format | Online Article Text |
id | pubmed-8182522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-81825222021-06-22 Clinico-pathological classification of rheumatic mitral valve damage and surgical strategy Luo, Tiange Meng, Xu J Thorac Dis Original Article BACKGROUND: There is a lack of established pathological indications for rheumatic valve repair. Therefore, we summarized the pathological classifications of rheumatic heart diseases and their correlations with the surgical strategies. METHODS: This observational study enrolled patients with rheumatic heart diseases who underwent mitral valve repair (MVP) or replacement at our centre between January 2017 and January 2019. Mitral leaflet, mitral commissural, and sub-valvular apparatus were classified into three grades from mild to severe, according to their degree of pathological damage. Based on certain principles and the grade of mitral leaflet, mitral commissural, and sub-valvular apparatus damage, three pathological types were identified (types I to III), based on which all patients were classified. The features of each pathological type were summarised. Differences between the three pathological types were analysed using chi-square test of tendency. These data were used to propose a clinico-pathological classification of rheumatic mitral valve damage in Chinese patients. RESULTS: Of 398 patients, 284 (70%) underwent MVP for rheumatic mitral valve diseases. There were 58 type I (15%) patients in the study, all of whom underwent repair (repair rate, 100%). Preoperative moderate-to-severe regurgitation with mild pathological lesions was observed in 64% of these patients. In 260 type II (65%) patients, the repair rate was 76% (197/260); preoperative moderate-to-severe stenosis was observed in 88% of these patients. In 80 type III (20%) patients, the repair rate was 36% (29/80); the preoperative rates of extremely severe stenosis and moderate-to-severe regurgitation in these patients were 50% and 40%, respectively. Several preoperative parameters show the change in trend with the increase in the pathological classification severity. CONCLUSIONS: Our clinico-pathological classification of rheumatic mitral valve damage is applicable to MVP. Considering that the classification principles are based on the possibility of mitral repair, it provides a phased and achievable target ratio for MVP and a principle of screening patients who should undergo rheumatic MVP. AME Publishing Company 2021-05 /pmc/articles/PMC8182522/ /pubmed/34164184 http://dx.doi.org/10.21037/jtd-20-3456 Text en 2021 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Luo, Tiange Meng, Xu Clinico-pathological classification of rheumatic mitral valve damage and surgical strategy |
title | Clinico-pathological classification of rheumatic mitral valve damage and surgical strategy |
title_full | Clinico-pathological classification of rheumatic mitral valve damage and surgical strategy |
title_fullStr | Clinico-pathological classification of rheumatic mitral valve damage and surgical strategy |
title_full_unstemmed | Clinico-pathological classification of rheumatic mitral valve damage and surgical strategy |
title_short | Clinico-pathological classification of rheumatic mitral valve damage and surgical strategy |
title_sort | clinico-pathological classification of rheumatic mitral valve damage and surgical strategy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182522/ https://www.ncbi.nlm.nih.gov/pubmed/34164184 http://dx.doi.org/10.21037/jtd-20-3456 |
work_keys_str_mv | AT luotiange clinicopathologicalclassificationofrheumaticmitralvalvedamageandsurgicalstrategy AT mengxu clinicopathologicalclassificationofrheumaticmitralvalvedamageandsurgicalstrategy |